Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-894 vs duloxetine vs placebo in diabetic neuropathic pain
2007-001139-71Phase 2Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sofinicline in diabetic neuropathy (5 arms), sponsored by Abbott Laboratories. Primary endpoint: Weekly mean of 24-hour average pain score. Started Sep 2007; status: completed.
02
Drugs
sofinicline
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on 2007-001139-71.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001139-71.